Cypress Capital’s Twist Bioscience TWST Stock Holding History

Cypress Capital’s Portfolio TWST Stock Details TWST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-5,635	Closed	-$255K	–	86
2024 Q3	$255K	Sell	5,635 -5,835	-51%	-$278K	0.07%	73
2024 Q2	$565K	Buy	+11,470	New	+$468K	0.14%	65
2024 Q1	–	Sell	-5,635	Closed	-$208K	–	83
2023 Q4	$208K	Hold	5,635	–	–	0.06%	76
2023 Q3	$114K	Hold	5,635	–	–	0.03%	80
2023 Q2	$115K	Hold	5,635	–	–	0.03%	81
2023 Q1	$85K	Buy	+5,635	New	+$124K	0.03%	70
2022 Q3	–	Sell	-5,778	Closed	-$202K	–	173
2022 Q2	$202K	Sell	5,778 -32	-0.6%	-$1.13K	0.03%	171
2022 Q1	$287K	Hold	5,810	–	–	0.04%	175
2021 Q4	$450K	Buy	+5,810	New	+$596K	0.05%	150

Other funds holding TWST

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Cypress Capital's TWST Position: Q4 2024 in Review

Cypress Capital sold out of Twist Bioscience (TWST) in Q4 2024, closing a stake of 5,635 shares — an estimated $255K sold.

Cypress Capital first reported a position in TWST in Q4 2021 and held it in 9 quarters. The position peaked at $565K in Q2 2024. 246 funds tracked by Wall St. Rank hold TWST as of Q4 2024.

Cypress Capital reported no remaining Twist Bioscience position as of Q4 2024 after selling out during the quarter.
Cypress Capital sold 5,635 Twist Bioscience shares in Q4 2024, an estimated $255K.
Cypress Capital first reported a position in Twist Bioscience in Q4 2021 and held it in 9 quarters.
Cypress Capital's Twist Bioscience position peaked at $565K in Q2 2024.
246 funds tracked by Wall St. Rank held Twist Bioscience as of Q4 2024.

Based on Cypress Capital's 13F filing for Q4 2024, filed 3 Feb 2025.